MyMedR

Displaying all 3 publications

Abstract:

Sort:

Rituximab in Childhood and Juvenile Pemphigus Vulgaris: A Systematic Review

Shrivastava P, Mariam S, Abid L, Buch SA, Ahmad SA, Mansoori S, et al.

Cureus, 2024 Apr;16(4):e58288.
PMID: 38752055 DOI: 10.7759/cureus.58288

Pemphigus vulgaris (PV) is a chronic autoimmune blistering disorder characterized by the loss of intraepithelial adhesion, affecting the skin and mucous membranes. Both males and females are affected, although it predominantly affects females in their fifth and sixth decades of life. Approximately 1.4 to 3.7% of PV cases occur in the pediatric population (≤18 years of age), and may be classified into childhood/pediatric PV, which affects individuals under 12 years old, and juvenile/adolescent PV, affecting those between 12 and 18 years old. Due to its rare occurrence in children and adolescents, there is often a delay in diagnosis and treatment in this age group. A systematic literature search was conducted on MEDLINE/PubMed, Web of Science, EMBASE, SCOPUS, and Cochrane Library databases to evaluate the efficacy of rituximab (RTX) in childhood and juvenile PV patients. The Joanna Briggs Institute (JBI) Critical Appraisal Checklist was employed to assess the risk of bias in case reports and series, while the Cochrane ROBINS-I tool was utilized for evaluating observational studies or non-randomized intervention studies. A total of 18 studies encompassing 46 juvenile or childhood PV patients in the pediatric and adolescent age groups were included for qualitative synthesis. The studies included nine case reports, two case series, five retrospective studies, one prospective study, and one open-label pilot study. Almost all cases of childhood and juvenile PV achieved either complete or partial remission after undergoing RTX treatment during the final follow-up periods. Furthermore, most cases reported no relapse, and only minor adverse events were noted in the RTX treatment group. Despite its potential benefits, the utilization of RTX in pediatric patients raises concerns due to the scarcity of evidence and the absence of controlled studies specific to this age group. Further exploration is necessary to establish a standardized treatment regimen for RTX in pediatric PV, which involves identifying the optimal dosage, frequency, treatment cycle duration, and maintenance therapy duration.
Fulltext Efficacy of 4% articaine vs 2% lidocaine in mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis: a systematic review and meta-analysis

Miglani S, Ansari I, Patro S, Mohanty A, Mansoori S, Ahuja B, et al.

PeerJ, 2021;9:e12214.
PMID: 34631321 DOI: 10.7717/peerj.12214

OBJECTIVE: The goal of this systematic review and meta-analysis is to determine the performance of 4% Articaine vs. 2% Lidocaine for mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis (IP).
METHODS: PubMed/MEDLINE, Cochrane Central Register of Controlled Trials, Web of Science, Google Scholar, and Open Gray were used to conduct a thorough literature search. A manual search of the reference lists of the publications found was also carried out. Two reviewers critically evaluated the papers for inclusion and exclusion criteria, and data extraction was done on the selected publications. The Cochrane Collaboration Tool and the Minors checklist were used to assess the quality of the selected studies for randomised controlled trials (RCTs) and non-randomised studies, respectively. The RevMan software was used to perform a meta-analysis of the pooled data and subgroups according to the technique of anaesthetic solution delivery, as well as a sensitivity analysis (P
Fulltext Effects of the COVID-19 lockdown and recovery on People's mobility and air quality in the United Arab Emirates using satellite and ground observations

Shanableh A, Al-Ruzouq R, Hamad K, Gibril MBA, Khalil MA, Khalifa I, et al.

Remote Sens Appl, 2022 Apr;26:100757.
PMID: 36281297 DOI: 10.1016/j.rsase.2022.100757

The stringent COVID-19 lockdown measures in 2020 significantly impacted people's mobility and air quality worldwide. This study presents an assessment of the impacts of the lockdown and the subsequent reopening on air quality and people's mobility in the United Arab Emirates (UAE). Google's community mobility reports and UAE's government lockdown measures were used to assess the changes in the mobility patterns. Time-series and statistical analyses of various air pollutants levels (NO2, O3, SO2, PM10, and aerosol optical depth-AOD) obtained from satellite images and ground monitoring stations were used to assess air quality. The levels of pollutants during the initial lockdown (March to June 2020) and the subsequent gradual reopening in 2020 and 2021 were compared with their average levels during 2015-2019. During the lockdown, people's mobility in the workplace, parks, shops and pharmacies, transit stations, and retail and recreation sectors decreased by about 34%-79%. However, the mobility in the residential sector increased by up to 29%. The satellite-based data indicated significant reductions in NO2 (up to 22%), SO2 (up to 17%), and AOD (up to 40%) with small changes in O3 (up to 5%) during the lockdown. Similarly, data from the ground monitoring stations showed significant reductions in NO2 (49% - 57%) and PM10 (19% - 64%); however, the SO2 and O3 levels showed inconsistent trends. The ground and satellite-based air quality levels were positively correlated for NO2, PM10, and AOD. The data also demonstrated significant correlations between the mobility and NO2 and AOD levels during the lockdown and recovery periods. The study documents the impacts of the lockdown on people's mobility and air quality and provides useful data and analyses for researchers, planners, and policymakers relevant to managing risk, mobility, and air quality.

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links